Obtaining the prestigious PMDA certification in Japan.
After more than two years of intense work, we are proud to announce the obtaining of the prestigious authorization to sell for EchoS device in Japan issued by the PMDA Japan: Pharmaceuticals and Medical Devices Agency of Japan.
The important milestone is a further international recognition for Echolight obtained through a scrupulous work with the Japanese agency and the commercial partner Toyo Medic, a consolidated reality in the distribution of innovative medical devices that has signed an important exclusive sales agreement in the Japanese territory for the Echolight range of products.
In Japan, the issue of bone health is so crucial that the Japanese Ministry of Health, Labor and Welfare has undertaken a survey to quantify the costs related to deficiencies in bone density and structure, as well as the costs related to fractures in the older population. age 65 and it has been estimated that total costs have been nearly 944 billion Japanese yen (8 billion US dollars) and are increasing rapidly.
With the introduction of R.E.M.S. Japan is at the forefront in the diagnosis of osteoporosis, demonstrating its foresight by adopting a new concept of bone health based on prevention, early diagnosis and monitoring throughout the whole life aimed at reducing the risk of fragility fracture with direct benefits towards patients as well as the sustainability of their healthcare system.
In fact, the revolutionary EchoS device, for bone micro-architecture assessment of the lumbar vertebrae and the femoral neck, based on the proprietary and patented R.E.M.S. (Radiofrequency Echographic Multi Spectrometry), being radiation-free, fast, portable and accurate, it significantly increases the accessibility to the test for the entire Japanese population, favoring prevention and early diagnosis.
The expansion of Echolight and the adoption of R.E.M.S. by an ever-growing number of countries, now numbering over 40 around the world.
For more information:
“Short-Term Precision and Repeatability of Radiofrequency Echographic Multi Spectrometry (REMS) on Lumbar Spine and Proximal Femur: An In Vivo Study" Carmelo Messina, Salvatore Gitto, Roberta Colombo, Stefano Fusco, Giada Guagliardo, Mattia Piazza, Jacopo Carlo Poli,...
Osteoporosis World Congress. Echolight flies to Barcelona REMS technology will be featured in a major symposium on fragility fracture prevention at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. The company will be located at stand...
A month full of collaborations with various Italian companies that care about prevention is coming to an end. The agreement with the Prada Group stands out. Health and fashion go hand in hand on the way to prevention. In April 2023, month dedicated to prevention and...